西亚试剂：Synergistic Innate and Adaptive Immune Response to Combinat

发布时间：2026-02-05

Cancer immunotherapies under development have generally focused on either stimulating T cell immunity or driving antibody-directed effector functions of the innate immune system such as antibody-dependent cell-mediated cytotoxicity (ADCC). We find that a combination of an anti-tumor antigen antibody and an untargeted IL-2 fusion protein with delayed systemic clearance induces significant tumor control in aggressive isogenic tumor models via a concerted innate and adaptive response involving neutrophils, NK cells, macrophages, and CD8+ T cells. This combination therapy induces an intratumoral “cytokine storm” and extensive lymphocyte infiltration. Adoptive transfer of anti-tumor T cells together with this combination therapy leads to robust cures of established tumors and development of immunological memory

以上资料由西亚试剂：http://www.xiyashiji.com/ 提供

上一篇：西亚试剂：iPS中多能标记物的表达顺序
下一篇：西亚试剂：研究获得成神经细胞自我更新与分化功能网络图